The presence of probiotics in the combination of metformin and rapamycin led through one or more mechanisms, to the suppression of tumor size, delay in their development, significant inhibition of the inflammatory reaction, as well as a decrease in ROS production, lower cell proliferation, significant decrease in AMPK and inhibition of the phosphorylated mTOR. This evidence concerns the gene MTOR and neoplasm.